Skip to content

Drug interactions

Carbamazepine + Nintedanib

Severity: Moderate

Carbamazepine and Nintedanib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Carbamazepine may reduce nintedanib exposure and therefore its antifibrotic efficacy. Nintedanib is a P-glycoprotein substrate and a minor CYP3A4 substrate, both of which carbamazepine induces.

What this interaction means in plain words

Carbamazepine and Nintedanib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Carbamazepine belongs to Central Nervous System; Nintedanib belongs to Oncology.

Evidence level: Moderate

Why it happens

Induction of P-glycoprotein and CYP3A4 reduces nintedanib absorption and increases its elimination.

What to do

Prefer an alternative anticonvulsant without enzyme-inducing properties. If coadministration is necessary, monitor for reduced therapeutic response.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Carbamazepine and Nintedanib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Carbamazepine with Nintedanib?

MediHelp rates the interaction as moderate. Carbamazepine and Nintedanib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Carbamazepine may reduce nintedanib exposure and therefore its antifibrotic efficacy. Nintedanib is a P-glycoprotein substrate and a minor CYP3A4 substrate, both of which carbamazepine induces.

How serious is the interaction between Carbamazepine and Nintedanib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Prefer an alternative anticonvulsant without enzyme-inducing properties. If coadministration is necessary, monitor for reduced therapeutic response.

What other medicines interact with Carbamazepine?

MediHelp also lists interactions of Carbamazepine with, for example, Artemether / lumefantrine, Cabotegravir, Delamanid. The full list is on the Carbamazepine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in